IBI303

· Innovent Biologics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI303, covering 2018-06-04 to 2018-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis [Phase 3]